Literature DB >> 8427630

Interaction between cystatin-derived peptides and papain.

G Lalmanach1, J Hoebeke, T Moreau, M Brillard-Bourdet, M Ferrer-Ditt Martino, F Borras-Cuesta, F Gauthier.   

Abstract

The interaction between papain and synthetic peptides which tentatively mimic cystatin surfaces was investigated both enzymatically and structurally. Measurements of dissociation equilibrium constants for the interaction of papain with these peptides modified by successive deletions or substitutions demonstrated that the QVVAG segment, which is highly conserved throughout members of the cystatin superfamily, is essential for the interaction. The glycyl-containing (N-terminal) fragments and PW-containing (C-terminal) fragments were found to be of lesser importance, since each could be deleted without significantly modifying the interaction. These fragments improved the stability of the interacting QVVAG region, which appeared to be substrate-like in all peptides tested, as it was cleaved at the A-G bond upon peptide-papain interaction. Replacement of the A residue at the scissile bond of the QVVAG by a blocked cysteinyl residue reduced the rate of cleavage of the susceptible bond and therefore shifted the resulting peptide from a substrate to an inhibitor. Derivatization of this substituted peptide at its N- and C-terminal ends by fluoresceinyl groups resulted in a dramatic decrease in the Ki to 0.5 microM. This improvement in the inhibitory properties of the substituted and derivatized peptides was correlated with structural changes as analyzed by molecular dynamic calculations. The results were compared to those proposed for the mechanisms of inhibition by natural inhibitors of the cystatin superfamily.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8427630     DOI: 10.1007/bf01024910

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  36 in total

1.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

Review 2.  The cystatins: protein inhibitors of cysteine proteinases.

Authors:  V Turk; W Bode
Journal:  FEBS Lett       Date:  1991-07-22       Impact factor: 4.124

3.  Simulation of the inhibitory cystatin surface by a synthetic peptide.

Authors:  T Moreau; J Hoebeke; G Lalamanach; M Hattab; F Gauthier
Journal:  Biochem Biophys Res Commun       Date:  1990-02-28       Impact factor: 3.575

4.  Studies on the extended active site of papain.

Authors:  J Lowbridge; J S Fruton
Journal:  J Biol Chem       Date:  1974-11-10       Impact factor: 5.157

Review 5.  Safer proteinase treatment of sciatica. A biochemical preview of chymopapain inhibitors.

Authors:  A Grubb
Journal:  Acta Orthop Scand       Date:  1988-02

6.  Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases.

Authors:  G Salvesen; C Parkes; M Abrahamson; A Grubb; A J Barrett
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

7.  Significant effects of Z-Gln-Val-Val-OME, common sequences of thiol proteinase inhibitors on thiol proteinases.

Authors:  N Teno; S Tsuboi; N Itoh; H Okamoto; Y Okada
Journal:  Biochem Biophys Res Commun       Date:  1987-03-13       Impact factor: 3.575

8.  Fluorescein isothiocyanate-labeled casein assay for proteolytic enzymes.

Authors:  S S Twining
Journal:  Anal Biochem       Date:  1984-11-15       Impact factor: 3.365

9.  Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum.

Authors:  A Anastasi; M A Brown; A A Kembhavi; M J Nicklin; C A Sayers; D C Sunter; A J Barrett
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

10.  Human cystatin C. role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase.

Authors:  M Abrahamson; R W Mason; H Hansson; D J Buttle; A Grubb; K Ohlsson
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

View more
  3 in total

1.  Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors.

Authors:  C Serveau; G Lalmanach; M A Juliano; J Scharfstein; L Juliano; F Gauthier
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

2.  Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.

Authors:  G Lalmanach; C Serveau; M Brillard-Bourdet; J R Chagas; R Mayer; L Juliano; F Gauthier
Journal:  J Protein Chem       Date:  1995-11

3.  Repurposing the McoTI-II Rigid Molecular Scaffold in to Inhibitor of 'Papain Superfamily' Cysteine Proteases.

Authors:  Manasi Mishra; Vigyasa Singh; Meenakshi B Tellis; Rakesh S Joshi; Shailja Singh
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.